Updated:
Adaptin Bio
Adaptin Bio, Inc. develops therapies for oncology and central nervous system disorders that improve drug delivery to the brain and other tissues.
Overview
Adaptin Bio, Inc. develops therapies for oncology and central nervous system disorders that improve drug delivery to the brain and other tissues. Its Brain Bispecific T cell Engager (BRiTE) technology was developed by researchers at the Department of Neurosurgery at Duke University.
Website
adaptinbio.comGeneral information
Sector focus
BiotechLife Sciences
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Prefer a guided tour?
We’ll walk you through:
Interactive funding timelinesCustom mandate & allocation filters